She previously served as Director of Healthcare Investments at GE Ventures and as a Principal at Lemhi Ventures, a fund investing in health care services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech companies based on university intellectual property at University of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up health care delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven health care start-up companies.
Jessica currently serves on the boards of Avalon Healthcare Services, Eleanor Health, Genome Medical, Heartbeat Health, Vericred, and Wildflower Health and is a board observer at Abacus Insights. She has a breadth of company formation to growth stage experience across health tech-enabled services companies such as Bind On-Demand Health Insurance, Medication Management Systems, Arcadia.io, and PlanSource. Outside of Echo, Jessica serves on the Board of CareQuest Institute for Oral Health, a non-profit seeking to improve oral health for all, is a Trustee for Boston Medical Center’s Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children’s Hospital, and is a member of the National Association of Corporate Directors.
Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her Master of Business Administration with a focus on Healthcare Administration at Regis University.
Jessica is based out of Echo’s Boston, Massachusetts office.
As COVID-19 rips through communities, the pandemic has stress tested the world’s ability to adapt to an unsettling reality. While businesses work to recover a semblance of normalcy by shifting operations to the cloud and preserving routine, new technical and behavioral challenges reveal inadequacies throughout the healthcare industry. In the race to demonstrate stability and…